Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1871)
ARTIVION, INC. (AORT)
Berry Lance A — EVP, COO, CFO&Treasurer
Shares
715
Price
$28.55
Total Value
$20.41K
Shares Held After
210,112
% of Holdings
0.3%
Neuronetics, Inc. (STIM)
Chernett Jorey — 10% Owner
Shares
14,000
Price
$3.16
Total Value
$44.24K
Shares Held After
10,602,988
% of Holdings
0.1%
EDAP TMS SA (EDAP)
Annen Steven — SVP, Marketing&Product Mgmt.
Shares
5,000
Price
$4.75
Total Value
$23.75K
Shares Held After
136,490
% of Holdings
3.7%
EDAP TMS SA (EDAP)
WILLSEY LANCE — Director
Shares
50,000
Price
$4.75
Total Value
$237.50K
Shares Held After
1,291,780
% of Holdings
3.9%
EDAP TMS SA (EDAP)
Shah Sanket — General Counsel&Corp Sec
Shares
5,000
Price
$4.75
Total Value
$23.75K
Shares Held After
72,500
% of Holdings
6.9%
EDAP TMS SA (EDAP)
Rhodes Ryan — Director
Shares
21,000
Price
$4.75
Total Value
$99.75K
Shares Held After
626,649
% of Holdings
3.4%
EDAP TMS SA (EDAP)
LEVINE JOSHUA — Director
Shares
10,000
Price
$4.75
Total Value
$47.50K
Shares Held After
45,000
% of Holdings
22.2%
EDAP TMS SA (EDAP)
Mobeck Kenneth S. — Chief Financial Officer
Shares
5,000
Price
$4.75
Total Value
$23.75K
Shares Held After
181,610
% of Holdings
2.8%
EDAP TMS SA (EDAP)
Schulz Fran — Director
Shares
10,000
Price
$4.75
Total Value
$47.50K
Shares Held After
15,100
% of Holdings
66.2%
EDAP TMS SA (EDAP)
Horn David R. — Director
Shares
10,000
Price
$4.75
Total Value
$47.50K
Shares Held After
10,000
% of Holdings
100.0%
Krystal Biotech, Inc. (KRYS)
ROSSI DINO A — Director
Shares
40
Price
$333.23
Total Value
$13.33K
Shares Held After
50,000
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
ROSSI DINO A — Director
Shares
3,095
Price
$331.43
Total Value
$1.03M
Shares Held After
50,040
% of Holdings
5.8%
Krystal Biotech, Inc. (KRYS)
ROSSI DINO A — Director
Shares
4,896
Price
$330.36
Total Value
$1.62M
Shares Held After
53,135
% of Holdings
8.4%
Krystal Biotech, Inc. (KRYS)
ROSSI DINO A — Director
Shares
7,428
Price
$329.60
Total Value
$2.45M
Shares Held After
58,031
% of Holdings
11.3%
Krystal Biotech, Inc. (KRYS)
ROSSI DINO A — Director
Shares
1,687
Price
$328.52
Total Value
$554.21K
Shares Held After
65,459
% of Holdings
2.5%
Krystal Biotech, Inc. (KRYS)
ROSSI DINO A — Director
Shares
5,226
Price
$327.39
Total Value
$1.71M
Shares Held After
67,146
% of Holdings
7.2%
Krystal Biotech, Inc. (KRYS)
ROSSI DINO A — Director
Shares
2,287
Price
$326.60
Total Value
$746.94K
Shares Held After
72,372
% of Holdings
3.1%
Krystal Biotech, Inc. (KRYS)
ROSSI DINO A — Director
Shares
341
Price
$325.60
Total Value
$111.03K
Shares Held After
74,659
% of Holdings
0.5%
Oruka Therapeutics, Inc. (ORKA)
Quinlan Paul T — General Counsel
Shares
3,847
Price
$111.14
Total Value
$427.55K
Shares Held After
31,034
% of Holdings
11.0%
Oruka Therapeutics, Inc. (ORKA)
Quinlan Paul T — General Counsel
Shares
9,193
Price
$110.00
Total Value
$1.01M
Shares Held After
34,881
% of Holdings
20.9%
Oruka Therapeutics, Inc. (ORKA)
Quinlan Paul T — General Counsel
Shares
10,200
Price
$109.11
Total Value
$1.11M
Shares Held After
44,074
% of Holdings
18.8%
Oruka Therapeutics, Inc. (ORKA)
Quinlan Paul T — General Counsel
Shares
14,696
Price
$107.97
Total Value
$1.59M
Shares Held After
54,274
% of Holdings
21.3%
Oruka Therapeutics, Inc. (ORKA)
Quinlan Paul T — General Counsel
Shares
10,434
Price
$107.14
Total Value
$1.12M
Shares Held After
68,970
% of Holdings
13.1%
Oruka Therapeutics, Inc. (ORKA)
Quinlan Paul T — General Counsel
Shares
3,630
Price
$106.05
Total Value
$384.96K
Shares Held After
79,404
% of Holdings
4.4%
Shares
1,800
Price
$0.06
Total Value
$111.60
Shares Held After
9,355,456
% of Holdings
0.0%
AbCellera Biologics Inc. (ABCL)
Booth Andrew — Chief Financial Officer
Shares
37,200
Price
$10.32
Total Value
$383.90K
Shares Held After
482,800
% of Holdings
7.7%
Green Thumb Industries Inc. (GTII/GTBIF)
Barnes Dawn Wilson — Director
Shares
5,250
Price
$7.21
Total Value
$37.85K
Shares Held After
65,936
% of Holdings
7.4%
Medline Inc. (MDLN)
GIC Private Ltd — 10% Owner
Shares
1,500,000
Price
$35.80
Total Value
$53.70M
Shares Held After
22,902,482
% of Holdings
6.1%
MDxHealth SA (MDXH)
MVM Partners, LLC — Director
Shares
2,202,643
Price
$0.45
Total Value
$1000.00K
Shares Held After
6,903,100
% of Holdings
31.9%
Dyne Therapeutics, Inc. (DYN)
Friedl-Naderer Johanna — Chief Commercial Officer
Shares
226
Price
$26.28
Total Value
$5.94K
Shares Held After
153,982
% of Holdings
0.1%
Cue Biopharma, Inc. (CUE)
Meluzio Michael Vincent — VP, Prin. Accounting Officer
Shares
3
Price
$31.13
Total Value
$93.39
Shares Held After
48,961
% of Holdings
0.0%
Cue Biopharma, Inc. (CUE)
Meluzio Michael Vincent — VP, Prin. Accounting Officer
Shares
4,106
Price
$30.35
Total Value
$124.62K
Shares Held After
48,964
% of Holdings
7.7%
Cue Biopharma, Inc. (CUE)
Meluzio Michael Vincent — VP, Prin. Accounting Officer
Shares
1,519
Price
$29.37
Total Value
$44.61K
Shares Held After
53,070
% of Holdings
2.8%
OMEROS CORP (OMER)
Borges David J. — VP, Finance&CAO
Shares
5,000
Price
$16.95
Total Value
$84.75K
Shares Held After
0
% of Holdings
100.0%
Butterfly Network, Inc. (BFLY)
ROBBINS LARRY — Director
Shares
175,300
Price
$8.86
Total Value
$1.55M
Shares Held After
4,371,387
% of Holdings
3.9%
Butterfly Network, Inc. (BFLY)
ROBBINS LARRY — Director
Shares
500,000
Price
$9.24
Total Value
$4.62M
Shares Held After
11,743,530
% of Holdings
4.1%
Butterfly Network, Inc. (BFLY)
ROBBINS LARRY — Director
Shares
215,233
Price
$9.54
Total Value
$2.05M
Shares Held After
12,243,530
% of Holdings
1.7%
Cue Biopharma, Inc. (CUE)
Ray Sumita — Chief Legal Compliance Officer
Shares
4
Price
$31.13
Total Value
$124.52
Shares Held After
118,545
% of Holdings
0.0%
Cue Biopharma, Inc. (CUE)
Ray Sumita — Chief Legal Compliance Officer
Shares
6,442
Price
$30.35
Total Value
$195.51K
Shares Held After
118,549
% of Holdings
5.2%
Cue Biopharma, Inc. (CUE)
Ray Sumita — Chief Legal Compliance Officer
Shares
2,383
Price
$29.37
Total Value
$69.99K
Shares Held After
124,991
% of Holdings
1.9%
Doximity, Inc. (DOCS)
Sitaram Siddharth — Chief Accounting Officer
Shares
1,770
Price
$24.94
Total Value
$44.14K
Shares Held After
97,004
% of Holdings
1.8%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
63,643
Price
$26.20
Total Value
$1.67M
Shares Held After
751,411
% of Holdings
7.8%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
94,415
Price
$26.20
Total Value
$2.47M
Shares Held After
1,045,735
% of Holdings
8.3%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
268,354
Price
$26.20
Total Value
$7.03M
Shares Held After
3,801,128
% of Holdings
6.6%
ROCKET PHARMACEUTICALS, INC. (RCKT)
Wilson Martin — General Counsel
Shares
3,493
Price
$3.38
Total Value
$11.81K
Shares Held After
674,484
% of Holdings
0.5%
908 Devices Inc. (MASS)
Knopp Kevin J. — Director
Shares
7,622
Price
$10.06
Total Value
$76.68K
Shares Held After
575,968
% of Holdings
1.3%
ROCKET PHARMACEUTICALS, INC. (RCKT)
Shah Gaurav — CEO
Shares
2,837
Price
$3.38
Total Value
$9.59K
Shares Held After
1,058,887
% of Holdings
0.3%
4D Molecular Therapeutics, Inc. (FDMT)
Bizily Scott — Chief Legal Officer
Shares
1,635
Price
$12.00
Total Value
$19.62K
Shares Held After
8,617
% of Holdings
15.9%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Shulman Joseph — Chief Technical Officer
Shares
5,079
Price
$119.75
Total Value
$608.21K
Shares Held After
15,915
% of Holdings
24.2%
UFP TECHNOLOGIES INC (UFPT)
FELDMANN CYNTHIA L — Director
Shares
1,000
Price
$324.26
Total Value
$324.26K
Shares Held After
4,476
% of Holdings
18.3%
Showing 251–300 of 1871 transactions (page 6 of 38)